Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Duloxetine 60–120 mg Once Daily in Chronic Low Back Pain
2006-003484-31Phase 3Completed
- Sponsor
- Eli Lilly and Company
- Start
- Oct 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in chronic low back pain (CLBP) comparing Duloxetine arm with Placebo arm (2 arms). Primary endpoint: Weekly mean of 24-hour average pain severity. Started Oct 2006; status: completed.
02
Drugs
duloxetine
03
Conditions
chronic low back pain (CLBP)
Beyond the preview
Go deeper on 2006-003484-31.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-003484-31.